Focal Choroidal Excavation Expansion Following Treatment of Associated Choroidal Neovascular Membrane

Copyright 2019, SLACK Incorporated.

Bibliographische Detailangaben
Veröffentlicht in:Ophthalmic surgery, lasers & imaging retina. - 2013. - 51(2019), 1 vom: 01. Dez., Seite 54-57
1. Verfasser: Kovacs, Kyle D (VerfasserIn)
Weitere Verfasser: Gonzalez, Luis A, Weiss, Stephanie J, Kiss, Szilard, Orlin, Anton
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2019
Zugriff auf das übergeordnete Werk:Ophthalmic surgery, lasers & imaging retina
Schlagworte:Case Reports Journal Article Research Support, Non-U.S. Gov't Angiogenesis Inhibitors Coloring Agents Recombinant Fusion Proteins VEGFA protein, human Vascular Endothelial Growth Factor A aflibercept 15C2VL427D mehr... Receptors, Vascular Endothelial Growth Factor EC 2.7.10.1 Indocyanine Green IX6J1063HV
Beschreibung
Zusammenfassung:Copyright 2019, SLACK Incorporated.
The authors describe a case of a previously unreported phenomenon of focal choroidal excavation (FCE) expansion, in absence of inflammation, due to treatment of an associated choroidal neovascular membrane (CNVM). A patient with new type 2 CNVM, treated during 43 months of follow-up with aflibercept, experienced significant expansion of an FCE with conversion from nonconforming to conforming type. FCE is part of the pachychoroid spectrum and the regression of an associated CNVM during aflibercept treatment as seen in the authors' patient may elucidate the pathogenesis of some forms of focal choroidal excavation and their evolution over time. [Ophthalmic Surg Lasers Imaging Retina. 2020;51:54-57.]
Beschreibung:Date Completed 14.08.2020
Date Revised 14.08.2020
published: Print
Citation Status MEDLINE
ISSN:2325-8179
DOI:10.3928/23258160-20191211-08